Relmada Therapeutics (RLMD)'s 30-day implied volatility (IV30) was 73.4% at the close on October 23, 2026, up from 73.2% the day before, against a 52-week range of 46.4% to 151.1%. Its 20-day historical volatility was 59.0%.
Data as of October 23, 2026.